| 标题 |
 Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy |
| 网址 | |
| DOI | |
| 其它 |
期刊：Kidney International 作者：Jonathan Barratt; Richard Lafayette; Jens Kristensen; Andrew Stone; Daniel Cattran; et al 出版日期：2022-10-19 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
XX
Dong021
Kao
GingerF
Criminology34
OK
无极微光
Logan
null
独特的项链
谪仙
mmyhn
有人
W sir
GODV
heekkll
好好
xuz
皖公网安备34019202002308
